MOTS-C / Tesamorelin (30 Day)

$299.99 / month

A 30-day clinician-guided combination explored for metabolic and body-composition goals.

Powered by Qualiphy

Explore a two-pathway approach to metabolic and body-composition goals with clear clinical guardrails.

How the components differ: MOTS-C is an investigational mitochondrial-derived peptide being studied for metabolic signaling. Tesamorelin stimulates growth-hormone release.

What to expect: Your clinician should assess glucose control, cancer history, HIV/lipodystrophy status, swelling, joint symptoms, pregnancy, and other medications. Monitoring may include glucose and IGF-1.

Reviews

Be the first to review “MOTS-C / Tesamorelin (30 Day)”

Your email address will not be published. Required fields are marked *